Search by Drug Name or NDC

    NDC 25021-0115-51 Clindamycin 150 mg/mL Details

    Clindamycin 150 mg/mL

    Clindamycin is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is CLINDAMYCIN PHOSPHATE.

    Product Information

    NDC 25021-0115
    Product ID 25021-115_d8c15b1b-89ef-4a7d-8352-66fafad2ad3f
    Associated GPIs 16220020302031 16220020302032 16220020302033 16220020302034
    GCN Sequence Number 009344
    GCN Sequence Number Description clindamycin phosphate VIAL 150 MG/ML INJECTION
    HIC3 W1K
    HIC3 Description LINCOSAMIDE ANTIBIOTICS
    GCN 40843
    HICL Sequence Number 004045
    HICL Sequence Number Description CLINDAMYCIN PHOSPHATE
    Brand/Generic Generic
    Proprietary Name Clindamycin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Clindamycin Phosphate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 150
    Active Ingredient Units mg/mL
    Substance Name CLINDAMYCIN PHOSPHATE
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090108
    Listing Certified Through 2024-12-31

    Package

    NDC 25021-0115-51 (25021011551)

    NDC Package Code 25021-115-51
    Billing NDC 25021011551
    Package 1 BOTTLE in 1 CARTON (25021-115-51) / 60 mL in 1 BOTTLE
    Marketing Start Date 2012-05-15
    NDC Exclude Flag N
    Pricing Information N/A